BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21105205)

  • 1. [Hasty dead certain conclusions about TNF inhibitors].
    Lindberg M
    Ugeskr Laeger; 2010 Nov; 172(45):3125; author reply 3125. PubMed ID: 21105205
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biological first-choice preparations in Region H].
    Graudal N; Jacobsen S; Baslund B; Jürgens G
    Ugeskr Laeger; 2010 Nov; 172(45):3127. PubMed ID: 21105207
    [No Abstract]   [Full Text] [Related]  

  • 3. [The rheumatologists' conflict of interest and biological medicines].
    Gøtzsche PC; Lundh A
    Ugeskr Laeger; 2010 Nov; 172(45):3126; author reply 3126. PubMed ID: 21105206
    [No Abstract]   [Full Text] [Related]  

  • 4. [Danish data document therapeutic effect differences of tumor necrosis factor inhibitors in patient with rheumatoid arthritis].
    Hetland ML
    Ugeskr Laeger; 2010 Jun; 172(26):2003; author reply 2003-4. PubMed ID: 20681045
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor necrosis factor inhibitors for rheumatoid arthritis.
    Scott DL; Kingsley GH
    N Engl J Med; 2006 Aug; 355(7):704-12. PubMed ID: 16914706
    [No Abstract]   [Full Text] [Related]  

  • 6. [Review of the protective effects of tumor necrosis factor inhibitors in rheumatoid arthritis].
    Finckh A; Gabay C; Guerne PA
    Rev Med Suisse Romande; 2004 Sep; 124(9):547-50. PubMed ID: 15552748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug survival on TNF inhibitors: 2003-2004 data from Italian National Register (GISEA Register).
    Iannone F; Ferraccioli G; Gremese E; Lapadula G;
    Ann Rheum Dis; 2014 Jun; 73(6):e31. PubMed ID: 24368512
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumor necrosis factor inactivation in the management of rheumatoid arthritis.
    Baumgartner SW
    South Med J; 2000 Aug; 93(8):753-9. PubMed ID: 10963503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-TNF-alpha therapies: they are all the same (aren't they?).
    Mpofu S; Fatima F; Moots RJ
    Rheumatology (Oxford); 2005 Mar; 44(3):271-3. PubMed ID: 15561736
    [No Abstract]   [Full Text] [Related]  

  • 10. Rheumatoid arthritis.
    Burchini G; Orsi C
    N Engl J Med; 2004 Sep; 351(13):1360-1; author reply 1360-1. PubMed ID: 15385669
    [No Abstract]   [Full Text] [Related]  

  • 11. [TNF-alpha inhibitors and demyelinating disease].
    Böttiger Y
    Lakartidningen; 2007 Nov 7-13; 104(45):3384. PubMed ID: 18062640
    [No Abstract]   [Full Text] [Related]  

  • 12. [TNF antagonists in therapy of rheumatoid arthritis].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 1999 Nov; 22(11):334-9. PubMed ID: 10596266
    [No Abstract]   [Full Text] [Related]  

  • 13. [The efficacy of the three available anti-tumour necrosis factor therapies in patients with rheumatoid arthritis. A meta-analytic literature review--secondary publication].
    Christensen R; Kristensen LE; Geborek P; Danneskiold-Samsøe B; Saxne T; Bliddal H
    Ugeskr Laeger; 2009 Jun; 171(26):2192-4. PubMed ID: 19678436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 'alphabet' of rheumatoid arthritis treatment.
    Capriotti T
    Medsurg Nurs; 2004 Dec; 13(6):420-8. PubMed ID: 15714747
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacotherapy of rheumatoid arthritis in the era of genetically engineered biological preparations].
    Nasonov EL
    Ter Arkh; 2007; 79(5):5-8. PubMed ID: 17672066
    [No Abstract]   [Full Text] [Related]  

  • 16. New drugs for rheumatoid arthritis.
    Messori A; Santarlasci B; Vaiani M
    N Engl J Med; 2004 Aug; 351(9):937-8. PubMed ID: 15329436
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biological agents for therapy of rheumatoid arthritis--overview].
    Takeuchi T
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():513-6. PubMed ID: 15799409
    [No Abstract]   [Full Text] [Related]  

  • 18. Disease-modifying antirheumatic drugs: enhancing efficacy by combination.
    Schnabel A
    Lancet; 2004 Feb; 363(9410):670-1. PubMed ID: 15001319
    [No Abstract]   [Full Text] [Related]  

  • 19. TNF blocker drugs used to fight inflammation go head-to-head. Adalimumab had highest treatment response and remission rates, etanercept has longest drug survival rates; infliximab placed third.
    Duke Med Health News; 2010 Mar; 16(3):3. PubMed ID: 20461880
    [No Abstract]   [Full Text] [Related]  

  • 20. Differentiating the efficacy of tumor necrosis factor inhibitors.
    Haraoui B
    J Rheumatol Suppl; 2005 Mar; 74():3-7. PubMed ID: 15742457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.